|
|
 |
|
 |
|
|
|
|
Title:
|
Leukemia Centralized Reference Laboratories and Tissue Repositories, Ancillary - IRB# 99-081A
|
|
Treatments:
|
13-cis retinoic acid, Tissue repository
|
|
Disease Site:
|
Leukemia
|
|
Disease SubSite:
|
Tissue repository
|
|
Drug Provided:
|
-- none --
|
|
Comments:
|
SWOG (Reimbursement for the submission of specimens to this banking protocol will be made based on the requirements of each associated treatment protocol).
|
|
Eligibility:
|
Patients must be registered on a Southwest
Oncology Group leukemia treatment study on or after the date of activation of this study.
|
|
Participating Sites:
|
Adventist Medical Center, Northwest Cancer Specialists, Providence Milwaukie Hospital, Providence Portland Medical Center, Providence St. Vincent Medical Center, Southwest Washington Medical Center
|
|
|
|
|
 |
|
 |
|
|
|